Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,630 papers from all fields of science
Search
Sign In
Create Free Account
Alkaptonuria
Known as:
Alcaptonuria
, Alkaptonuria [Disease/Finding]
, AKU
Expand
A rare autosomal recessive disorder characterized by abnormalities in the metabolism of phenylalanine and tyrosine. It results in the accumulation in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
Narrower (1)
Alkaptonuric ochronosis
Broader (3)
Amino Acid Metabolism, Inborn Errors
Fetal Diseases
Nutritional and Metabolic Diseases
Aortic dilatation
Aortic valve calcification
Autosomal recessive inheritance
Back Pain
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of…
L. Ranganath
,
A. Milan
,
+32 authors
J. Rovenský
Annals of the Rheumatic Diseases
2014
Corpus ID: 21595108
Background Alkaptonuria (AKU) is a serious genetic disease characterised by premature spondyloarthropathy. Homogentisate-lowering…
Expand
Review
2013
Review
2013
Recent advances in management of alkaptonuria (invited review; best practice article)
L. Ranganath
,
J. Jarvis
,
J. Gallagher
Journal of Clinical Pathology
2013
Corpus ID: 24860734
Alkaptonuria (AKU) is an autosomal recessive condition arising as a result of a genetic deficiency of the enzyme homogentisate 1…
Expand
Highly Cited
2011
Highly Cited
2011
The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria.
A. M. Taylor
,
A. Boyde
,
+5 authors
J. Gallagher
Arthritis & Rheumatism
2011
Corpus ID: 29027284
OBJECTIVE Alkaptonuria is a genetic disorder of tyrosine metabolism, resulting in elevated circulating concentrations of…
Expand
Review
2004
Review
2004
Alkaptonuria, ochronosis, and ochronotic arthropathy.
A. Mannoni
,
E. Selvi
,
+6 authors
B. Porfirio
Seminars in Arthritis & Rheumatism
2004
Corpus ID: 25726206
OBJECTIVES To describe the clinical presentation and course of a relatively large group of Italian adult patients screened for…
Expand
Review
1998
Review
1998
Cutaneous deposition diseases. Part II.
Diane M. Touart
,
P. Sau
Journal of American Academy of Dermatology
1998
Corpus ID: 28907763
Highly Cited
1998
Highly Cited
1998
Characterization of a Fungal Maleylacetoacetate Isomerase Gene and Identification of Its Human Homologue*
J. Fernández-Cañón
,
M. Peñalva
Journal of Biological Chemistry
1998
Corpus ID: 28820866
We have previously used Aspergillus nidulans as a fungal model for human phenylalanine catabolism. This model was crucial for our…
Expand
Highly Cited
1996
Highly Cited
1996
The molecular basis of alkaptonuria
J. Fernández-Cañón
,
B. Granadino
,
+4 authors
S. R. Córdoba
Nature Genetics
1996
Corpus ID: 7809387
Alkaptonuria (AKU) occupies a unique place in the history of human genetics because it was the first disease to be interpreted as…
Expand
Highly Cited
1996
Highly Cited
1996
Alkaptonuria: such a long journey
Charles R. Scriver
Nature Genetics
1996
Corpus ID: 205342756
MITF (microphthalmia–associated transcription factor) encodes a transcription factor with a basic–helix–loop–helix–zipper (bHLH…
Expand
Highly Cited
1969
Highly Cited
1969
Oxidation of homogentisic acid to ochronotic pigment in connective tissue.
V. Zannoni
,
N. Lomtevas
,
S. Goldfinger
Biochimica et Biophysica Acta
1969
Corpus ID: 19396829
Review
1963
Review
1963
Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: Review of world literature (1584–1962)
W. O'Brien
,
B. Du
,
J. J. Bunim
1963
Corpus ID: 58358627
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE